Hypothesis

Age‑related decline of CYP2F1 in club cells directly drives p16INK4a‑dependent senescence by allowing accumulation of specific lipid‑derived electrophiles that activate the DNA‑damage response. Restoring CYP2F1 expression in aged club cells will lower these electrophiles, reduce p16 expression, and reinstate self‑renewal and differentiation capacity.

Mechanistic Basis

CYP2F1 metabolizes arachidonic acid and linoleic acid derivatives to generate hydroxylated fatty acids that act as endogenous ligands for the nuclear receptor PPARγ. PPARγ activation promotes antioxidant gene expression (e.g., HO‑1, NQO1) and suppresses the cGAS‑STING pathway, which otherwise senses cytosolic DNA and triggers p16 upregulation via p38 MAPK. In aging lungs, reduced CYP2F1 lowers PPARγ‑activating metabolites, leading to diminished PPARγ signaling, increased cytosolic DNA sensing, and heightened p16 expression. Simultaneously, unmetabolized fatty acids undergo non‑enzymatic peroxidation, producing electrophiles such as 4‑hydroxynonenal (4‑HNE) that covalently modify Keap1, impairing Nrf2‑mediated antioxidant responses and further elevating ROS. This creates a feed‑forward loop where oxidative stress stabilizes p16 and suppresses club cell proliferation.

Predictions

1. Aged mice with club‑cell‑specific CYP2F1 overexpression will show decreased 4‑HNE adducts, increased PPARγ target gene expression, and reduced γH2AX foci compared with aged controls.
2. p16INK4a mRNA and protein levels in isolated club cells will be significantly lower in CYP2F1‑overexpressing aged lungs, correlating with elevated Ki‑67 and SCGB1A1 (club cell marker) expression after naphthalene injury.
3. Functional repair, measured by epithelial thickness and mucus clearance 7 days post‑injury, will be restored to levels seen in young adult mice only when CYP2F1 is rescued.
4. Pharmacologic inhibition of PPARγ will blunt the anti‑senescent effect of CYP2F1 overexpression, confirming pathway dependence.

Experimental Approaches

• Generate a club‑cell‑specific Cre‑driver (SCGB1A1‑CreERT2) crossed to a Rosa26‑lox‑STOP‑lox‑CYP2F1 allele; induce CYP2F1 expression in 18‑month‑old mice.
• Validate overexpression by qPCR, immunoblot, and activity assay (ethoxycoumarin O‑deethylation).
• Quantify senescence markers (p16, SA‑β‑gal) and DNA damage (γH2AX) in fluorescence‑sorted club cells.
• Measure lipid‑derived electrophiles via LC‑MS (4‑HNE, aldehyde‑phospholipids).
• Assess PPARγ signaling (PPARγ target genes, nuclear translocation) and Nrf2 activity (ARE‑luciferase reporter in primary club cells).
• Perform naphthalene (250 mg/kg, i.p.) injury model; evaluate epithelial regeneration histologically and functionally (airway compliance, mucociliary clearance).
• Include controls: aged WT, aged CYP2F1‑overexpressing with PPARγ antagonist (GW9662), and young adult mice.

If CYP2F1 restoration reduces p16, lowers electrophilic stress, and improves repair, the hypothesis is supported. Failure to observe these changes would falsify the claim that CYP2F1 decline is a causal driver of club cell senescence.